| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |